Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Clover Health Investments’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001801170-26-000122
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net medical claims incurred | 589,648 | 353,442 |
| Salaries and benefits | 57,063 | 59,022 |
| General and administrative expenses | 74,629 | 50,675 |
| Depreciation and amortization | 515 | 466 |
| Total operating expenses | 721,855 | 463,605 |
| Income (loss) from operations | 27,334 | (1,274) |
| Net income (loss) | $27,334 | $(1,274) |
| Per share data: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Clover Health Investments's D&A?
- Clover Health Investments (CLOV) reported D&A of $515K in Q1 2026.
- How has Clover Health Investments's D&A changed year-over-year?
- Clover Health Investments's D&A increased by 10.5% year-over-year, from $466K to $515K.
- What is the long-term trend for Clover Health Investments's D&A?
- Over 3 years (2021 to 2025), Clover Health Investments's D&A has grown at a 10.6% compound annual growth rate (CAGR), from $1.25M to $1.69M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Clover Health Investments's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude